BioLife Solutions
BLFS
80 hedge funds and large institutions have $168M invested in BioLife Solutions in 2019 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 42 increasing their positions, 16 reducing their positions, and 10 closing their positions.
163% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 16
0% more funds holding
Funds holding: 80 → 80 (0)
0% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 10
0.32% less ownership
Funds ownership: 50.36% → 50.04% (-0.32%)
2% less capital invested
Capital invested by funds: $170M → $168M (-$2.87M)
59% less call options, than puts
Call options by funds: $179K | Put options by funds: $437K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$1.32M |
| 2 |
RC
Roubaix Capital
Denver,
Colorado
|
+$952K |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$850K |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$756K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$740K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.49M |
| 2 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$2.33M |
| 3 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
-$2.01M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.19M |
| 5 |
SCM
Sandler Capital Management
New York
|
-$975K |
BLFS Hedge Fund Activity: Q4 2019 in Review
80 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q4 2019, worth a combined $168M — down 1.7% from $170M a quarter earlier.
Fund positioning in BLFS was balanced in Q4 2019: 10 funds opened new positions, 10 closed out, 42 added to existing stakes and 16 trimmed.
The largest buyer was Park West Asset Management, adding an estimated $1.32M. The largest seller was Fidelity Investments, exiting entirely with an estimated $2.49M sold.
- 80 institutional investors held BioLife Solutions (BLFS) as of Q4 2019, unchanged from Q3 2019.
- Funds reported $168M of BioLife Solutions stock for Q4 2019, down 1.7% quarter-over-quarter.
- 10 funds opened new BioLife Solutions positions in Q4 2019 and 10 closed out, a net change of 0 holders.
- The largest BioLife Solutions buyer in Q4 2019 was Park West Asset Management, an estimated $1.32M added.
- The largest BioLife Solutions seller in Q4 2019 was Fidelity Investments, an estimated $2.49M sold.
Based on aggregated 13F filings for Q4 2019.